• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma


0.7900 USD 0.0200 2.60%

As of 20:10:00 ET on 12/26/2014.

Snapshot for GTx Inc (GTXI)

Open: 0.7900 Day's Range: 0.7600 - 0.8200 Volume: 227,944
Previous Close: 0.7700 52wk Range: 0.4100 - 2.3500 1-Yr Rtn: -51.83%

Stock Chart for GTXI

No chart data available.
  • GTXI:US 0.7900
  • 1D
  • 1M
  • 1Y
Interactive GTXI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for GTXI

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.4557
Est. EPS (USD) (12/2014) -0.3700
Est. PEG Ratio -
Market Cap (M USD) 110.86
Shares Outstanding (M) 140.33
30 Day Average Volume 248,477
Price/Book (mrq) 5.6567
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/04/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for GTXI

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for GTXI

GTx, Inc. discovers, develops, and commercializes therapeutics primarily related to the treatment of serious men's health conditions. The Company's drug discover and development programs are focused on small molecules that selectively modulate the effects of estrogens and androgens, two essential classes of hormones. GTx is currently developing products for prostate cancer.

Marc S HanoverPresident/Interim CEO/COOHenry P DoggrellVP/Chief Legal Officer/Secy
Jeffrey G HesselbergVP:Regulatory AffairsMary Ann JohnstonVP:Medical Affairs
More Company Profile & Key Executives for GTXI

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil